Treatment of myocardial fibrosis in systemic sclerosis with tocilizumab. 2021.07.14 Tweet Share Impact factor 5 over 雑誌：Rheumatology, 2021;60(6)：e205-e206. 著者：Ishizaki Yoshiki, Ooka Seido, Doi Shunichi, Kawasaki Tatsuya, Sakurai Keiichi, Mizushima Machiko, Kiyokawa Tomofumi, Takakuwa Yukiko, Tonooka Kumiko, Kawahata Kimito.. Tweet Share Potential impact of right atrial pressur…前の記事 Post-COVID-19 postural orthostatic tachy…次の記事
Impact factor 5 over 雑誌：Rheumatology, 2021;60(6)：e205-e206. 著者：Ishizaki Yoshiki, Ooka Seido, Doi Shunichi, Kawasaki Tatsuya, Sakurai Keiichi, Mizushima Machiko, Kiyokawa Tomofumi, Takakuwa Yukiko, Tonooka Kumiko, Kawahata Kimito..
